M
Mineralys Therapeutics Inc
NASDAQ:MLYS
Mineralys Therapeutics Inc
NASDAQ:MLYS
Price:
26.895
USD
0.65%
Market Closed
Market Cap:
$2.1B
Balance Sheet
Balance Sheet Decomposition
Mineralys Therapeutics Inc
Mineralys Therapeutics Inc
Balance Sheet Decomposition is not available for
Mineralys Therapeutics Inc
Mineralys Therapeutics Inc
Balance Sheet
Mineralys Therapeutics Inc
Mineralys Therapeutics Inc
Currency: USD
| Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|
| Assets | ||||||
| Cash & Cash Equivalents |
1
|
11
|
88
|
49
|
114
|
|
| Cash |
1
|
11
|
88
|
1
|
1
|
|
| Cash Equivalents |
0
|
0
|
0
|
49
|
113
|
|
| Short-Term Investments |
0
|
0
|
22
|
187
|
84
|
|
| Other Current Assets |
0
|
1
|
3
|
13
|
7
|
|
| Total Current Assets |
1
|
11
|
113
|
249
|
205
|
|
| PP&E Net |
0
|
0
|
0
|
0
|
0
|
|
| Long-Term Investments |
0
|
0
|
0
|
2
|
0
|
|
| Other Long-Term Assets |
0
|
0
|
2
|
0
|
0
|
|
| Total Assets |
1
N/A
|
11
+649%
|
114
+929%
|
252
+120%
|
206
-18%
|
|
| Liabilities | ||||||
| Accounts Payable |
1
|
1
|
2
|
1
|
0
|
|
| Accrued Liabilities |
0
|
4
|
6
|
10
|
14
|
|
| Short-Term Debt |
5
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
0
|
0
|
1
|
0
|
0
|
|
| Total Current Liabilities |
5
|
5
|
8
|
10
|
15
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
|
| Total Liabilities |
5
N/A
|
5
-1%
|
8
+60%
|
10
+30%
|
15
+40%
|
|
| Equity | ||||||
| Common Stock |
0
|
29
|
159
|
0
|
0
|
|
| Retained Earnings |
4
|
23
|
53
|
125
|
303
|
|
| Additional Paid In Capital |
0
|
0
|
1
|
366
|
494
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
4
N/A
|
6
N/A
|
106
+1 652%
|
241
+127%
|
191
-21%
|
|
| Total Liabilities & Equity |
1
N/A
|
11
+649%
|
114
+929%
|
252
+120%
|
206
-18%
|
|
| Shares Outstanding | ||||||
| Common Shares Outstanding |
37
|
37
|
37
|
41
|
50
|
|
Switch to:
Switch to:
See Also
Discover More
